Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 184 results found. Search for [ Zydus Cadila ]

Results 1 to 21 of 184
PB Jayakumar
New Delhi, January 7, 2020
How the merger of MNC giants Bayer and Monsanto is likely to pan out in India


E Kumar Sharma
New Delhi, January 1, 2020
Biosimilars are a different ball game -- more complex and more expensive, essentially because biotech drugs, by their very nature, require understanding of living organisms


PB Jayakumar
December 30, 2019
The USFDA's Office of Manufacturing Quality (OMQ) at the Centre for Drug Evaluation Research (CDER) evaluates compliance with cGMP for drugs based on inspection reports and evidence gathered by USFDA investigators


BusinessToday.In
December 12, 2019
Share Market LIVE : On Thursday, Tata Motors, SBI, YES Bank, Tata Steel, Vedanta were among the top gainers. ONGC, Bharti Airtel, Bharti Infratel, HCl Tech and Infosys were among the top losers.    


BusinessToday.In
December 11, 2019
Ujjivan Small Finance Bank, Vodafone Idea, YES Bank, Bharti Airtel, Maruti,CCD, Zydus Cadila, Adani Transmission Limited, Ultratech Cement are among the top stocks to watch out for Thursday's trading session


E Kumar Sharma
New Delhi, November 25, 2019
A number of biologics with huge markets are going off-patent in the US. Do Indian pharmaceutical companies have it in them to play this high-cost, high-risk game of launching biosimilars?


BusinessToday.In
November 21, 2019
Cadila Healthcare share price has lost 29% in one year and fallen 27% since the beginning of this year


BusinessToday.In
November 14, 2019
Following the acquisition of the remaining 15% stake each in its subsidiaries Zydus Technologies Ltd and Zydus Noveltech Inc, the two companies will become wholly-owned subsidiaries of Cadila Healthcare Ltd


PB Jayakumar
New Delhi, November 12, 2019
The divestment will curtail 13 per cent global revenues of Lupin, which had posted Rs 16,369 crore consolidated revenues for the financial year ended March 31, 2019


PB Jayakumar
November 6, 2019
Most violations relate to rectifiable documentation, data maintenance, batch-wise consistent production quality, data on supply chain, stability issues, microbial contamination and quality checks


BusinessToday.In
November 4, 2019
The USFDA warning letter will not affect the existing business of Cadila Healthcare in the US and the existing product supplies from the Moraiya facility will continue


BusinessToday.In
November 4, 2019
Cadila Healthcare share which opened at Rs 257 against previous close of Rs 255.30 hit an intra day high of Rs 260.6 (2.08%)


PB Jayakumar
New Delhi, September 24, 2019
Ranitidine, an old molecule with sales of $412.4 million is found to have cancer-causing impurities


E Kumar Sharma
September 5, 2019
Even as smaller Indian companies are looking to grow their business in the US market, the larger focus is on leading pharma companies because the top 20 of them contribute 75 per cent to total pharma exports from India


PTI
August 9, 2019
Drug firm Cadila Healthcare on Friday reported a consolidated net profit of Rs 303.6 crore for the quarter ended June 30, 2019.


E Kumar Sharma
New Delhi, July 24, 2019
Analysts expect a better show in Q1 thanks to a combination of factors such as overall business improvement in the Unites States and a pick-up in demand in the domestic market.


PB Jayakumar
New Delhi, July 22, 2019
Zydus Cadila, India's fourth-largest drug company by revenue, is banking big on research of new drugs, even though others have bowed out. Zydus expects the new drug business to grow to Rs 3,500 crore in four-five years


PB Jayakumar
New Delhi, June 10, 2019
In spite of an expanding healthcare market, prevention and wellness do not get the attention they deserve


Dr Sharvil Patel
N\, June 10, 2019
Focus should be on preventive product development to help promote people's wellness over a long period


PTI
June 3, 2019



PAGES 1 OF 10  12345